European journal of organic chemistry

How Iboga Alkaloids May Interrupt Addiction

Updated

Abstract

Ibogaine, a major alkaloid from the iboga root, may help reduce substance use in rodents but poses risks in humans.

  • Ibogaine has shown potential to lower self-administration of opiates, amphetamines, alcohol, and nicotine in rodent studies.
  • Despite its anti-addictive properties, ibogaine's cardiotoxicity and hallucinogenic effects limit its use in treating Substance Use Disorder (SUD) in humans.
  • Efforts are underway to understand ibogaine's action and develop safer alternatives.
  • There have been over twenty total syntheses of ibogamine and ibogaine, but fewer for recently isolated iboga alkaloids.
  • This review focuses on the synthetic methods used for both classical and non-classical iboga alkaloids.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free